Mike Wilson: Mid-Year U.S. Equities Outlook - Be Selective
Chief Investment Officer Mike Wilson explains why sector and style preferences—along with selective stock picking—may be the key to success for the rest of 2021.
17 Touko 20213min
Andrew Sheets: Inflation - Is It Here to Stay?
The debate over inflation was center stage this week and although the current environment is a far cry from the 1970s, rising prices could mean complications for both companies and central banks.
14 Touko 20213min
Special Episode: How Worrying Are Global Supply Chain Issues?
Labor shortages and inventory constraints are weighing on U.S. manufacturing and shipping. How severe could the impact be to U.S. GDP and multi-industry revenues?
13 Touko 202110min
Michael Zezas: The Bumpy Road Ahead for U.S. Infrastructure
Differing U.S. infrastructure policy approaches highlight the ongoing difficulties of bipartisanship in Washington. Here’s one possible outcome.
12 Touko 20212min
Special Encore: What Are Other Investors Thinking?
Original release April 16th, 2021: Keeping tabs on how other investors are trading can do more than just satisfy curiosity. It can provide a window into trends and current market debates.
11 Touko 20212min
Mike Wilson: Welcome to the Mid-Cycle Transition
Amid pricey valuations and growing evidence of labor and supply chain issues investors may want to adjust focus as we exit the early stages of the recovery.
10 Touko 20214min
Andrew Sheets: Why (and How) Jobs Numbers Matter
With U.S. labor market numbers coming in below expectations, Andrew Sheets assesses how jobs data feeds into market and policy maker thinking about the road to recovery.
7 Touko 20213min
Special Episode: Is Herd Immunity Even Possible?
Amid declining rates of vaccinations in the U.S, virus mutations and a crisis in India, is herd immunity from COVID-19 still achievable? The latest insights from Biotech equity analyst, Matthew Harrison.
6 Touko 202111min
